Medical device company BD (Becton, Dickinson and Company) has announced 85 new jobs.
The positions will be created as part of a €30m investment to expand BD's manufacturing facility in Enniscorthy, Co Wexford.
The company has also officially opened a €4m research and development facility in Blackrock in Dublin which will house 35 high-tech workers and complement an existing R&D facility in Limerick, which employs more than 300 people.
The Blackrock facility will focus on the commercialisation of an on-body injector device known as the BD Evolve.
The centre will also serve as the regional base of operations for BD's sales, technical service and corporate functional support teams.
"BD first established operations in Ireland in 1964, and since then has grown to four locations that employ more than 1,100 people across the country," said Roland Goette, President of BD for Europe, Middle East and Africa.
"Ireland has proven to be a smart place to invest in both R&D, as well as manufacturing operations, and our new R&D centre in Blackrock and €30 million investment in Enniscorthy are proof of BD’s long-term commitment to Ireland," Mr Goette said.
Minister of State for the Department of Enterprise, Trade and Employment Neale Richmond welcomed the investments by BD.
"The projects will create more than 85 new jobs in Ireland with opportunities for our talented workforce to be part of exciting new medical advancements at BD," Mr Richmond said.
IDA Executive Director Mary Buckley said the investments by BD underscored the strategic importance of Ireland in the company's global operations.
"It is proof of the company's future commitment to the country and testament to Ireland and indeed our region’s continued attractiveness as a location for investment," Mr Lohan said.
